Wird geladen...
Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
Triple inhaled corticosteroid (ICS)/long-acting muscarinic antagonist (LAMA)/long-acting β(2)-agonist (LABA) therapy is recommended for symptomatic patients with chronic obstructive pulmonary disease (COPD) and at risk of exacerbations. However, the benefits versus side-effects of triple inhaled the...
Gespeichert in:
| Veröffentlicht in: | ERJ Open Res |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
European Respiratory Society
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5934530/ https://ncbi.nlm.nih.gov/pubmed/29750142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00119-2017 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|